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Overview 
All animals are equipped with the capacity for rapid motor 
response that excitable cells--nerve and muscle--medi- 
ate. Voltage-sensitive ion channels on the surface mem- 
branes allow the cells to generate brief and reversible alter- 
ations of the voltage (action potentials) along the surface 
of these cellular cables. Ion channels, notably those con- 
ducting Na +, Ca 2+, and W, are large proteins with mem- 
brane-spanning pores that are regulated by both voltage 
sensors and gates in the same polypeptide. The critical 
role of ion channels in all excitable cells, and the complex 
interplay of activation and inactivation of the different ion 
currents underlying the action potential, has led many to 
suggest that inherited defects of voltage-sensitive chan- 
nels could be incompatible with life. 
This view dramatically changed four years ago when 
the gene coding for the major ~ subunit of the human 
muscle sodium channel was isolated, localized to chromo- 
some 17q, and found to show genetic linkage to hyperka- 
lemic periodic paralysis (hyperPP) (Fontaine et al., 1990). 
Patients with this hereditary disorder show episodic loss 
of excitability of skeletal muscle. Soon after, two additional 
muscle disorders, paramyotonia congenita (PC) and po- 
tassium-aggravated myotonia (PAM), were linked to this 
same locus (Koch et al., 1991 ; Ptd~ek et al., 1991a; Ebers 
et al., 1991). The most common inherited disorder of 
horses was then found to be linked to the equine homolog 
of the same gene (Rudolph et al., 1992). 
Over the last two years, two additional human hereditary 
muscle diseases showing membrane excitation abnormal- 
ities, myotonia congenita (MC) and hypokalemic periodic 
paralysis (hypoPP), were linked to genes encoding the 
chloride and calcium ion channels (Koch et al., 1992; Fon- 
taine et al., 1994). As the amino acid changes underlying 
these disorders have been identified and characterized, 
this disease-based research has complemented ongoing 
in vitro mutagenesis and electrophysiological studies in 
the search for structure-function relationships in the chan- 
nel molecules. Thus far, accumulated knowledge has re- 
sulted in a greater understanding of most facets of these 
disorders, from basic molecular pathophysiology to better 
patient diagnosis and management. 
The Muscle Sodium Channel Diseases 
The three hereditary muscle diseases in this group 
(hyperPP, PC, and PAM; see Rfidel et al., 1993, for review) 
are all inherited as dominant raits. Interestingly, the patho- 
physiology includes both hyper- and hypoexcitability, fre- 
quently in the same patient at different imes. Fortunately 
for the patients, the presenting symptoms of muscle stiff- 
ness (myotonia) and muscle weakness (paralysis) are in- 
termittent. The attacks are typically triggered by exposure 
to cold (PC), ingestion of potassium-rich food (PAM), or 
rest after a heavy work load (hyperPP). The symptoms 
usually disappear spontaneously within an hour or so, and 
attacks can be prophylactically treated with medication or 
avoided by behavior modification (i.e., avoidance of high 
potassium foods or vigorous exercise). Nonetheless, symp- 
toms can pose an unwelcome burden on the activites of 
daily living for these patients. 
Prior to molecular studies, electrophysiological experi- 
ments on excised muscle specimens from patients re- 
vealed the presence of a noninactivating Na ÷ current (Leh- 
mann-Horn et al., 1981, 1987). If these results reflected 
the primary defect, then the key symptoms of stiffness 
and weakness could be caused by the same mechanism: 
a sustained but variable depolarization of the muscle fiber 
membranes. To determine whether the Na + changes were 
the site of the primary biochemical defect, genetic linkage 
analyses were done using the cloned human sodium chan- 
nel a subunit gene as a candidate. Both hyperPP and PC 
were found to be tightly genetically linked to the sodium 
channel gene on 17q (Fontaine et al., 1990; Pt&~ek et al., 
1991 a; Koch et al., 1991 ; Ebers et al., 1991). These reports 
were followed by a series of publications documenting sin- 
gle base changes in the sodium channel gene. The mutant 
genes express abnormal channel proteins with single 
amino acid changes that exert a dominant effect on the 
muscle action potential in both human and horse patient 
muscle (change-of-function) (Rojas et al., 1991 ; Pt&5ek et 
al., 1991b; Rudolph et al., 1992; McClatchey et al., 1992; 
Lerche et al., 1993; see R0del et al., 1993) (Figure 1, top). 
The sodium channel ~ subunit, a 260 kDa glycoprotein 
with about 1,800 amino acids, has four homologous do- 
mains, each containing 225-325 amino acids (Figure 1, 
top). Each of the four domains has at least six hydrophobic 
segments ($1-$6) that are thought o traverse the plasma 
membrane (see Catterall, 1988, for review). Between seg- 
ments $5 and $6 of each domain, the extracellular loop 
is thought o dip into the plasma membrane and participate 
in the formation of the pore, as has been shown more 
directly for the analogous region in potassium channels. 
The $4 hydrophobic helices have a high density of 
charged amino acids, and these charges are thought to 
participate in sensing voltage changes across the plasma 
membrane (voltage sensor). Another part of the protein 
to which a certain function has been assigned is the intra- 
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Figure 1. Mutations Identified in Muscle Ion Channels 
The chloride channel model is as proposed by Mitrovic et al. (1994), 
as modified by Middleton et al. (1994). 
cellular loop connecting domain Ill-S6 with domain IV-S1. 
Most likely, this part of the protein acts as the inactivation 
gate of the channel by swinging in and out of the intracellu- 
lar opening of the pore to regulate ion flow through the 
channel (Armstrong et al., 1973). 
Of the 16 disease-causing amino acid changes identi- 
fied to date, five result in PC, five in hyperPP, and six in 
PAM. At first glance, no obvious correlations can be made 
between the location or type of amino acid change and 
the clinical phenotype (Figure 1, top). However, none of 
the mutations are located in domain I, and only domains 
II and IV contain changes in transmembrane segments. 
The transmembrane mutations are never located in the 
center of the membrane, but instead are near the extracel- 
lular or intracellular face. Four amino acid changes have 
been detected in the part of the protein thought to act as 
the inactivation gate (111-$6 to IV-S1 linker) (Figure 1, top). 
Three of these mutations generate different amino acid 
changes for one of a pair of glycines known to be essential 
for proper channel inactivation (the so-called hinge site; 
West et al., 1992). The more the substitution differs from 
the normal glycine (longer side chains, greater charge, or 
both), the greater the membrane hyperexcitability and the 
more severe the clinical symptoms of PAM (Lerche et al., 
1993). A change from glycine to glutamic acid, an amino 
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Figure2. Faulty Sodium Channel Inactivation in a Potassium- 
Aggravated Myotonia Patient Mutation Expressed In Vitro 
Shown are patch-clamp data from normal (wild-type) and PAM 
(V1589M) sodium channels expressed in HEK293 cells. Both single- 
channel recordings during five depolarization pulses each (top) and 
channel open probabilities for late reopenings as a function of pulse 
number (center) show the tendency for late reopenings of the mutant 
channel. Current-versus-time plots (bottom) recorded in the whole-cell 
mode show a persistent inward Na ÷ current with the mutant channel. 
acid with a long side chain, causes permanent myotonia 
(the most severe form of PAM), and valine, an amino acid 
with a side chain of intermediate size, causes moderate 
myotonia, while alanine, with a short side chain, results 
in a benign, often subclinical form of myotonia. Similar 
associations of the severity of amino acid change with 
severity of clinical symptoms have been seen in cold- 
sensitive PC patients in whom a charged arginine in do- 
main IV-S4 is changed to a histidine, cysteine, or proline 
(Pt&~ek et al., 1991b; Wang et al., 1995). A patient having 
the proline change is a clinically severe PC patient who 
shows toe walking and marked cold sensitivity of both her 
myotonia and her subsequent weakness (Wang et al., 
1995). 
Expression of normal and mutant sodium channels in 
heterologous ystems has shown that all the mutant chan- 
nels studied to date have impaired inactivation of the Na + 
current (Figure 2) (Cannon and Strittmatter, 1993; Chahine 
et al., 1994; Mitrovic et al., 1994). Surprisingly, mutations 
leading to the different clinical phenotypes howed similar 
electrophysiological results: mutations present in PC, 
PAM, or hyperPP patients all showed an increased steady- 
state current, owing to a shift in the equilibrium between 
two gating modes of inactivation. The twelve amino acid 
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substitutions on the cytoplasmic surface of the channel 
probably alter N-type (ball and chain) inactivation of the 
channel; however, it is not clear why the five substitutions 
on the extracellular surface also affect fast inactivation. 
The extracellular surface m~tations may have uncovered 
a region of the sodium channel that is important for inacti- 
vation that was not previously identified via in vitro muta- 
genesis studies. The preponderance of amino acid changes 
affecting inactivation may simply be a consequence of the 
dominant inheritance pattern seen in all sodium channel 
diseases: faulty inactivation would be expected~o have a 
dominant effect on the myofiber. The mutantchannels 
have change-of-function alterations that lead to a persis- 
tent inward Na ÷ current, which in turn depolarizes the cell, 
first activating and then inactivating the normal sodium 
channels coexpressed in the myofibers of a heterozygous 
patient. On the other hand, mutations reducing activation 
or conductance would be expected to show a recessive 
inheritance pattern more consistent with loss-of-function 
of channel activity. Patients with recessively inherited so- 
dium channelopathies have not been identified; however, 
it is likely that such complete loss-of-function of the muscle 
sodium channel is not compatible with life. 
Most hyperPP, PC, and PAM patients are quite sensitive 
to elevations of systemic potassium or to cold tempera- 
tures. Surprisingly, the mutant channels do not seem to 
show a strong response to high extracellular potassium 
or low temperature in voltage-clamped membrane patch 
experiments. Perhaps factors that trigger attacks of myo- 
tonia or paralysis in vivo exert their effect indirectly, either 
by causing a persistent Na ÷ current via K÷-induced mem- 
brane depolarization in myofiber t tubules (hyperPP, PAM) 
(Cannon et al., 1993) or via cold-induced depolarization 
due to reduced sodium pump activity (PC). Alterations of 
the interaction of mutant channels with their environment 
(membrane or associated proteins) are also hypothesized. 
These effects may be seen only in mature myofibers and 
not in channels expressed in heterologous cell systems. 
Also puzzling is the apparent fine line between attacks of 
hyperexcitability (myotonia) and hypoexcitability (paraly- 
sis) in patients. The same amino acid change can alter- 
nately induce attacks of severe myotonia or severe paraly- 
sis, often in the same patient (the horse disease is a 
particularly dramatic example [Spier et al., 1990]). Current 
pathophysiological models suggest that mild depolariza- 
tions of the myofiber membrane (10-20 mV) from impaired 
inactivation of mutant channels serve to make the mem- 
brane hyperexcitable, with excessive contractions induced 
by voluntary muscle activity, experienced by the patient 
as muscle stiffness. On the other hand, when the depolar- 
izations caused by the abnormal channels are more se- 
vere (20-30 mV), both the normal and mutant sodium 
channels become fixed in a state of inactivation, causing 
weakness or paralysis in patients. Thus, the fine line be- 
tween myotonia and paralysis seen clinically may simply 
reflect subtle differences in the severity of membrane de- 
polarization (10-20 mV versus 20-30 mV). Fortunately in 
humans, the heart muscle (which uses a different sodium 
channel gene) and the diaphragm (which uses the same 
gene, but seems refractory to attacks) are spared; hence, 
attacks are not life-threatening in humans. Some affected 
horses, however, die from attacks as a result of shock or 
ischemia. 
The cellular and physiological factors dictating the onset 
and severity of attacks in hyperPP are other important 
areas of contin ued investigation. The relationships among 
exercise, systemic potassium, catecholamines, and other 
factors influencing muscle metabolism are currently being 
studied in horses with hyperPP. The horse has also been 
used to show the first correlation of levels of mutant mRNA 
relative to normal RNA as a likely determinant of clinical 
severity in dominantly inherited disease (Zhou et al., 
1994). Another interesting hypothesis concerns the possi- 
ble key role of K ÷ diffusion in the extensive t tubule system 
of myofibers in the development of paralytic attacks (Can- 
non et al., 1993). Finally, molecular mutation and pharma- 
cology studies are underway in human patients to deter- 
mine whether drug efficacy can be correlated with specific 
amino acid changes of the channel. 
Muscle Calcium Channel Disease 
When one considers calcium channels in skeletal muscle 
fibers, one initially thinks of excitation-contraction cou- 
pling, not the action potential itself. In hypokalemic peri- 
odic paralysis (hypoPP), clinical electrophysiological stud- 
ies had established that the problem resided in the failure 
of membrane excitation. Thus, it was surprising when this 
disorder was genetically linked to a muscle calcium chan- 
nel, specifically the ~1 subunit of the skeletal muscle dihy- 
dropyridine (DHP) receptor (voltage-sensitive calcium 
channel conducting the slow L-type Ca 2÷ current), a chan- 
nel involved much more in excitation-contraction coupling 
than action potentials (Fontaine et al., 1994). 
HypoPP is clinically very similar to hyperPP, with serum 
K ÷ levels as the major distinguishing laboratory finding: 
during an episode of paralysis, hypoPP patients have low 
levels of serum K ÷ (sometimes as low as 1.8 raM; normal 
levels are 3.5-5.0 raM), but levels in hyperPP patients are 
high (up to 7.0 mM). Additionally, hypoPP patients never 
show signs of myotonia, and episodes of paralysis tend 
to last longer and can be triggered by hormones such as 
insulin and adrenaline and by carbohydrate intake. 
The skeletal muscle DHP receptor is located primarily 
in the membrane of the transverse tubular system and 
consists of five subunits: a l ,  ~z2/8, ~, and 7 (Catterall, 
1988). The ~1 subunit (Figure 1, middle) contains the re- 
ceptor for dihydropyridines and other calcium channel an- 
tagonists as well as the ion-conducting pore. It is assumed 
to form physical associations with the calcium release 
channel of the sarcoplasmic reticulum (the ryanodine re- 
ceptor) and thus translate membrane potential changes 
to intracellular calcium release (excitation-contraction 
coupling). Although structurally very similar to the sodium 
channel (z subunit, several substructures have functions 
that are thought to be different. 
Soon after the demonstration of linkage of hypoPP to 
the gene encoding DHP receptor (zl, point mutations were 
detected that predict substitutions of histidine for arginine 
in II-$4 and IV-S4 (Jurkat-Rott et al., 1994; Pt~.ek et al., 
1994) (Figure 1, middle). The functional consequences of 
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these mutations are just now being explored. Whole-cell 
recordings from myotubes cultured from the muscles of 
patients with the mutation in iV-S4 revealed a reduction 
of the DHP-sensitive L-type current to 30% of the normal 
amplitude (Lehmann-Horn et al., 1995). Myotubes with the 
mutation in II-$4 show a dramatic shift in the inactivation 
curve to more negative potentials by 40 mV, driving chan- 
nels to the inactivated state at low membrane potentials 
(Sipos et al., 1995). Although the mutations reduce the 
number of positive charges in voltage sensors, they do 
not affect channel activation. There is a striking parallel 
in the sodium channel diseases, in that mutations of the 
analogous domain IV-S4 region of the sodium channel a 
subunit modify channel inactivation but not voltage- 
dependent activation (Chahine et al., 1994). However, 
electrophysiological studies of the mutant sodium chan- 
nels have clearly documented the expected change of 
function (persistent inward Na ÷ current), consistent with 
the dominant inheritance pattern of the disorder. The pre- 
liminary electrophysiology studies of the calcium channel 
mutations uggest instead a loss of function (decreased 
Ca 2+ current): this biochemical defect does not match the 
dominant inheritance pattern of hypoPP. As has occurred 
with the chloride channel (see below), the disease inheri- 
tance patterns may help define the larger order structure 
of the muscle calcium channel: the dominant inheritance 
may indicate that the functional channel could be com- 
posed of multiple c~ subunits, with amino acid changes 
in hypoPP causing dominant negative alterations of the 
channel. 
How the inactivation of the L-type Ca 2÷ current is related 
to hypokalemia-induced attacks of muscle weakness is 
still a mystery. The hypokalemia-induced membrane de- 
polarization observed in excised muscle fibers might re- 
duce Ca 2÷ release indirectly by inactivating sodium chan- 
nels, or directly by affecting the voltage control of the 
channel. The triggering of attacks by insulin and adrena- 
line may similarly be direct or indirect: both insulin and 
adrenaline have been shown to hyperpolarize muscle 
membranes (Li and Sperelakis, 1993). The markedly de- 
creased phenotypic expression of the mutations in women 
is not understood and is likely complex; however, this ob- 
servation may point to an effect of hormones on the muscle 
calcium channel. 
Muscle Chloride Channel Diseases 
Patients who show pure myotonia, with little sensitivity to 
cold or potassium levels, are usually given the diagnosis 
of MC. Both dominant and recessive inheritance patterns 
have been frequently found, with the dominant form taking 
the name of Thomsen (a physician noting the disorder in 
his own family), while the recessive form is called Becker 
myotonia. It was not previously clear whether these disor- 
ders represented ifferent mutations of the same gene or 
different genes. This issue was settled with the finding of 
genetic linkage of both disorders to the gene coding for 
the adult human muscle chloride channel (Koch et al., 
1992). 
In both dominant and recessive MC, the predominant 
symptom is muscle stiffness due to uncontrolled bursts 
of spontaneous action potentials. The myotonia is most 
severe during voluntary muscle activity following a period 
of rest. Pharmacological experiments on muscles from an 
animal model, the myotonic goat, showed a reduction of 
the CI- conductance of the muscle fiber membranes (Bry- 
ant, 1969). A similar CI- conductance defect was later 
found in both dominant and recessive MC in humans (Lip- 
icky et al., 1971; Redel et al., 1988). The genetic linkage 
analysis of MC pedigrees was made possible by the ex- 
pression cloning of the chloride channel from the Torpedo 
marmorata electric organ (CiC-0), a channel that shows 
very little homology to other ion channels (see Steinmeyer 
et al., 1994). 
The CIC-1 protein is responsible for the high resting 
membrane conductance of skeletal muscle cells. The 
functional channel is thought o be a homotetramer, with 
each subunit having approximately 1000 amino acids 
(Lorenz et al., 1994). To date, nine point mutations in ex- 
ons, a base change affecting a splice consensus site, and 
two deletions have been described in the human chloride 
channel gene (Figure 1, bottom); however, mutations have 
been found in only about 15% of unrelated MC patients 
studied to date. Three of the point mutations cause domi- 
nantly inherited Thomsen myotonia (George et al., 1993), 
with one of them occurring in Thomsen's own family 
(Steinmeyer et al., 1994). The remainder of the mutations 
appear to cause the recessive Becker form. It is important 
to note, however, that only 19 of 117 unrelated Becker 
patients are mutation positive, and only 5 of the 19 (25%) 
have had mutations identified on both C/C-1 alleles (Koch 
et al., 1992; Heine et al., 1994). Of these 5, 3 were homozy- 
gous for a single mutation, while the remaining 2 have 
been shown to be compound heterozygotes. All other pa- 
tients with the recessive form have had only one putative 
mutation identified and are presumed to have an unidenti- 
fied mutation on their other gene. The very large number 
of presumed compound heterozygotes is worrisome and 
requires further investigation. Moreover, some presumed 
disease-causing amino acid substitutions have been 
found in normal individuals, which leads one to ask 
whether these are harmless polymorphisms or actual mu- 
tations that cause recessive or dominant disease when 
combined with other base changes either in cis or in trans. 
Clearly, genotype-phenotype correlations in this disease 
are at an early stage, and these studies are complicated 
by both the double inheritance patterns and the relatively 
mild nature of the disease. 
CIC-1 forms a functional channel when it is expressed 
in Xenopus oocytes. Voltage-clamp analyses have shown 
that it conducts over the whole physiological voltage 
range, with inward-going rectification in the negative po- 
tential domain. Its single-channel conductance, estimated 
from noise analysis, is very low, near 1 pS (Pusch et al., 
1994). The large macroscopic CI- conductance, therefore, 
must result from a high channel density in the membrane. 
When CIC-1 channels containing amino acid substitutions 
leading to MC were expressed in oocytes, the CI- currents 
were completely missing (Steinmeyer et al., 1994). These 
data clearly suggest that many of the changes lead to a 
loss of function of the chloride channel. 
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Coexpression of wild-type CIC-1 with different mutant 
loss-of-function CIC-1 channels yielded interesting results 
that may explain why MC can be alternatively transmitted 
as either a dominant or a recessive trait (Steinmeyer et 
al., 1994). The functional chloride channel is most likely 
a homo-oligomer ofCIC-1 subu nits (Middleton et al., 1994), 
and the CIC-1 protein harboring the dominant amino acid 
change may oligomerize with the normal CIC-1 coexpressed 
in the same cell. The mutant subunit may then destroy the 
function of the entire complex; such dominantly inherited 
dominant negative mutations are common in proteins that 
form functional oligomers. Thus, both the recessive and 
dominant forms of the disease probably lead to a complete 
or near-complete loss of function of the CI- conductance. 
This conclusion is supported by experiments with myoto- 
nia-generating drugs, which have shown that blockage of 
50% of the physiological CI- current is not sufficient to 
produce myotonic activity (Palade and Barchi, 1977). 
Conclusion 
The ion channel mutations clearly do not permanently and 
irreversibly alter the capability of a patient to conduct ac- 
tion potentials in muscle; indeed, the mutation causing 
periodic paralysis in quarter horses has been shown to 
impart a distinct competitive advantage in the show ring 
(Naylor, 1994)! These mutations probably reflect an ascer- 
tainment bias: there are probably many more mutations 
that occur in muscle ion channels, but these are probably 
incompatible with life. Importantly, these mutations permit 
proper cell function until extra- or intracellular conditions 
(shifts in pH, electrolyte concentrations, temperature) ex- 
acerbate the molecular pathology, leading to episodic and 
catastrophic failure of channel function. The ion channel 
abnormalities illuminate the critical nature of the gating 
of voltage-dependent channels in intact muscle, and the 
possible effect of myofiber mileau on gating. 
Electrophysiological studies of the abnormal channels 
in excised muscle specimens or in heterologous expres- 
sion systems suggest that our current knowledge of chan- 
nel structure-function relationships is far from comprehen- 
sive. This is vividly illustrated by the finding of mutations in 
the important $4 transmembrane domain: this region has 
been clearly demonstrated in potassium and sodium chan- 
nels to function as a voltage sensor for channel activation, 
yet disease-causing mutations in the analogous region of 
domain IV of both the sodium and the calcium channel indi- 
cate that this region is important for inactivation as well. 
Important questions remain. What are the consequences 
of cold temperatures and systemic potassium levels on 
the mutant sodium channels containing single amino acid 
changes? The effects seen in vivo have not been well 
reproduced in in vitro expression studies, yet such effects 
define these clinical disorders. Why do all the mutations 
seem predominantly to alter inactivation of sodium chan- 
nels, rather than other channel subfunctions? Is this purely 
a consequence of patient ascertainment (i.e., viable muta- 
tions)? The chloride and calcium channelopathies have 
been studied much less extensively, and even more ques- 
tions exist. Particularly fascinating in the chloride channel- 
opathies is the effect of exercise on membrane xcitability, 
and the possible dominant negative effect of the mutant 
proteins on the normal channels in the same cell. The 
chloride channel diseases are unprecedented in human 
molecular genetics in the finding of only one mutant allele 
in the vast majority of recessive Becker myotonia cases. 
Do these patients truly represent complete loss of function 
of the chloride channels, and if so, where are the other 
mutations? Finally, the molecular basis for the majority 
(85%) of pure myotonia patients remains to be identified, 
an observation that suggests that the candidate gene ap- 
proach may continue to be fertile ground for research in 
the ion channelopathies. 
Despite the many questions, it is clear that human dis- 
ease has served as an informative xperimental system 
to study ion channel function. This system should continue 
to complement he ongoing methodical in vitro studies 
using more controllable and established heterologous 
assays. 
References 
Armstrong, C. M., BezaniUa, F, and Rojas, E. (1973). Destruction of 
sodium conductance in squid axons perfused with pronase. J. Gen. 
Physiol. 62, 375-391. 
Bryant, S. H. (1969). Cable properties of external intercostal muscle 
fibres from myotonic and nonmyotonic goats. J. Physiol. 204, 539- 
550. 
Cannon, S. C., and Strittmatter, S. M. (1993). Functional expression of 
sodium channel mutations identified in families with periodic paralysis. 
Neuron 10, 317-326. 
Cannon, S. C., Brown, R. H., Jr., and Corey, D. P. (1993). Theoretical 
reconstruction ofmyotonia nd paralysis caused by incomplete inacti- 
vation of sodium channels. Biophys. J. 65, 270-288. 
Catterall, W. A. (1988). Structure and function of voltage-sensitive ion 
channels. Science 242, 50-61. 
Chahine, M., George, A. L., Jr., Zhou, M., Ji, S., Sun, W., Barchi, 
R. L., and Horn, R. (1994). Sodium channel mutations inparamyotonia 
congenita uncouple inactivation from activation. Neuron 12, 281-294. 
Ebers, G. C., George, A. L., Barchi, R. L., Ting-Passador, S. S., Kallen, 
R. G., Lathrop, G. M., Beckmann, J. S., Hahn, A. F., Brown, W. F., 
Campbell, R. D., et al. (1991). Paramyotonia congenita nd hyperka- 
lemic periodic paralysis are linked to the adult muscle sodium channel 
gene. Ann. Neurol. 30, 810-816. 
Fontaine, B., Khurana, T. S., Hoffman, E. P., Bruns, G. A. P., Haines, 
J. L., Trofatter, J. A., Hanson, M. P., Rich, J., McFarlane, H., Yasek, 
D. M., Romano, D., Gusella, J. F., and Brown, R. H. (1990). Hyper- 
kalemic periodic paralysis and the adult muscle sodium channel 
a-subunit gene. Science 250, 1000-1003. 
Fontaine, B., Vale-Santos, J. M., Jurkat-Rott, K., Reboul, J., Plassart, 
E., Rime, C. S., Elbaz, A., Heine, R., Giumaraes, J., Weissenbach, J., 
et al. (1994). Mapping of the hypokalemic periodic paralysis (hypoPP) 
locus to chromosome lq31-32 in three European families. Nature 
Genet. 6, 267-272. 
George, A. L., Crackover, M. A., Abdalla, J. A., Hudson, J. A., and 
Ebers, G. C. (1993). Molecular basis of Thomsen's disease (autosomal 
dominant myotonia congenita). Nature Genet. 3, 305-310. 
Heine, R., George, A. L., Pika, U., Deymeer, F., RL3del, R., and Leh- 
mann-Horn, F. (1994). Proof of a non-functional muscle chloride chan- 
nel in recessive myotonia congenita (Becker) by detection of a 4 base 
pair deletion. Hum. Mol. Genet. 3, 1123-1128. 
Jurkat-Rott, K., Lehmann-Horn, F., Elbaz, A., Heine, R., Gregg, R. G., 
Hogan, K., Powers, P., Lapie, P., Vale-Santos, J. E., Weissenbach, 
J., and Fontaine, B. (1994). A calcium channel mutation causing hypo- 
kalemic periodic paralysis. Hum. Mol. Genet. 3, 1415-1419. 
Koch, M. C., Ricker, K., Otto, M., Grimm, T., Bender, K., Zoll, B., 
Lehmann-Horn, F., R0del, R., Harper, P. S., and Hoffman, E. P. (1991). 
Linkage data suggesting allelic heterogeneity for paramyotonia con- 
genita and hyperkalemic periodic paralysis. Hum. Genet. 88, 71-74. 
Koch, M. C., Steinmeyer, K., Ricker, K., Wolf, F., Otto, M., Zoll, B., 
Cell 
686 
Lehmann-Horn, F., Grzeschik, K. H., and Jentsch, T. J. (1992). Tight 
linkage of recessive and dominant forms of human myotonia to skeletal 
muscle chloride channel gene. Science 257, 797-800. 
Lehmann-Horn, F., R0del, R., Dengler, R., Lorkovic, H., Haass, A., 
and Ricker, K. (1981). Membrane defects in paramyotonia congenita 
with and without myotonia in a warm environment. Muscle Nerve 4, 
396-406. 
Lehmann-Horn, F., Kuther, G., Ricker, K., Grafe, P., Ballanyi, K., and 
R~Jdel, R. (1987). Adynamia episodica hereditaria with myotonia: a 
non-inactivating sodium current and the effect of extracellular pH. Mus- 
cle Nerve 10, 363-374. 
Lehmann-Horn, F., Sipos, I., Jurkat-Rott, K., Heine, R., Brinkmeier, 
H., Fontaine, B., Kovacs, L., and Melzer, W. (1995). Altered calcium 
currents in human hypokalernic periodic paralysis myotubes express- 
ing mutant L-type calcium channels. Proc. Soc. Gem Physiol., in press. 
Lerche, H., Heine, R., Pika, U., George, A. L., Mitrovic, N., Browatzki, 
M., Weiss, T., Bastide-Rivet, M., Franke, C., LoMonaco, M., Ricker, 
K., and Lehmann-Horn, F. (1993). Human sodium channel rnyotonia: 
slowed channel inactivation due to substitutions for a glycine within 
the Ill/IV linker. J. Physiol. 470, 13-22. 
Li, K. X., and Sperelakis, N. (1993). Isoproterenol- and insulin-induced 
hyperpolarization i  rat skeletal muscle. J. Cell. Physiol. 157, 631- 
636. 
Lipicky, R. J., Bryant, S. H., and Salmon, J. H. (1971). Cable parame- 
ters, sodium, potassium, chloride, and water content and potassium 
efflux in isolated external intercostal muscle of normal volunteers and 
patients with myotonia congenita. J. Clin. Invest. 50, 2091-2103. 
Lorenz, C., Meyer-Kleine, C., Steinmeyer, K., Koch, M. C., and 
Jentsch, T. J. (1994). Genomic organization of the human muscle 
chloride channel CIC-1 and analysis of novel mutations leading to 
Becker-type myotonia. Hum. Mol. Genet. 3, 941-946. 
McClatchey, A. I., Van den Bergh, P., Pericak-Vance, M. A., Raskind, 
W., Verellen, C., McKenna-Yasek, D., Rao, K., Haines, J. L., Bird, 
T., Brown, R. H., and Gusella, J. F. (1992). Temperature-sensitive 
mutations in the Ill-IV cytoplasmic loop region of the skeletal muscle 
sodium channel gene in paramyotonia congenita. Cell 68, 769-774. 
Middleton, R. E., Pheasant, D. J., and Miller, C. (1994). Purification, 
reconstitution, and subunit composition of a voltage-gated chloride 
channel from Torpedo Electroplax. Biochemistry 33, 13189-13198. 
Mitrovic, N., George, A. L., Jr., Heine, R., Wagner, S., Pika, U., Hart- 
laub, U., Zhou, M., Lerche, H., Fahlke, C., and Lehmann-Horn, F. 
(1994). Potassium-aggravated myotonia: the V1589M mutation desta- 
bilizes the inactivated state of the human muscle sodium channel. J. 
Physiol. 478, 395-402. 
Naylor, J. M. (1994). Selection of quarter horses affected with hyperka- 
lemic periodic paralysis by show judges. J. Am. Vet. Med. Assoc. 204, 
926-928. 
Palade, P. T., and Barchi, R. L. (1977). Characteristics of the chloride 
conductance in muscle fibers of the rat diaphragm. J. Gen. Physiol. 
69, 325-335. 
Pt~.~ek, L. J., Trimmer, J. S., Agnew, W. S., Roberts, J. W., Petajan, 
J. H., and Leppert, M. (199 la). Paramyotonia congenita and hyperka- 
lemic periodic paralysis map to the same sodium channel gene locus. 
Am. J. Hum. Genet. 49, 851-854. 
Pt&~ek, L. J., George, A. L., Griggs, R. C., Tawil, R., Kallen, R. G., 
Barchi, R. L., Robertson, M., and Leppert, M. F. (1991b). Identification 
of a mutation in the gene causing hyperkalemic periodic paralysis. 
Cell 67, 1021-1027. 
PtS~ek, L., Tawil, R., Griggs, R. C., Engel, A., Layzer, R. B., Kwiecir~ski, 
H., McManis, P. G., Santiago, L., Moore, M., Fouad, G., Bradley, P., 
and Leppert, M. F. (1994). Dihydropyridine receptor mutations cause 
hypokalemic periodic paralysis. Cell 77, 863-868. 
Pusch, M., Steinmeyer, K., and Jentsch, T. J. (1994). Low single chan- 
nel conductance of the major skeletal muscle chloride channel, CIC-1. 
Biophys. J. 66, 149-152. 
Rojas, C. V., Wang, J., Schwartz, L., Hoffman, E. P., Powell, B. R., 
and Brown, R. H., Jr. (1991). A methionine to valine mutation in the 
skeletal muscle sodium channel ~-subunit in human hyperkalemic pe- 
riodic paralysis. Nature 354, 387-389. 
RSdel, R., Ricker, K., and Lehmann-Horn, F. (1988). Transient weak- 
ness and altered membrane characteristic in recessive generalized 
myotonia (Becker). Muscle Nerve 11,202-211. 
R0del, R., Ricker, K., and Lehmann-Horn, F. (1993). Genotype- 
phenotype correlations in human skeletal muscle sodium channel dis- 
eases. Arch. Neurol. 50, 1241-1248. 
Rudolph, J. A., Spier, S. J., Byrns, G., and Hoffman, E. P. (1992). 
Linkage of hyperkalemic periodic paralysis in quarter horses to the 
horse adult skeletal muscle sodium channel gene. Animal Genet. 23, 
241-250. 
Rudolph, J. A., Spier, S. J., Byrns, G., Rojas, C. V., Bernoco, D., and 
Hoffman, E. P. (1992). Periodic paralysis in quarter horses: a sodium 
channel mutation disseminated by selective breeding. Nature Genet. 
2, 144-147. 
Sipos, I., Jurkat-Rott, K., Harasztosi, C., Fontaine, B., Kovacs, L., 
Melzer, W., and Lehmann-Horn, F. (1995). Skeletal muscle DHP recep- 
tor mutations alter calcium currents in human hypokalemic periodic 
paralysis myotubes. J. Physiol. 483, 299-306. 
Spier, S. J., Carlson, G. P., Holliday, T. A., Cardinet, G. H., and Pickar, 
J. G. (1990). Hyperkalemic periodic paralysis in horses. J. Am. Vet. 
Med. Assoc. 197, 1009-1017. 
Steinmeyer, K., Lorenz, C., Pusch, M., Koch, M. C., and Jentsch, T. J. 
(1994). Multirneric structure of CIC-1 chloride channel revealed by 
mutations in dominant myotonia congenita (Thornsen). EMBO J. 13, 
737-743. 
Wang, J. Z., Dubowitz, V., Lehmann-Horn, F., Ricker, K., Pt~.~ek, L., 
and Hoffman, E. P. (1995). In vitro structure/function studies: consecu- 
tive Arg1448 changes to Cys, His, and Pro at the extracellular surface 
of IVS4. Proc. Soc. Gen. Physiol., in press. 
West, J., Patton, D., Scheuer, T., Wang, Y., Goldin, A. L., and Catterall, 
W. A. (1992). A cluster of hydrophobic amino acid residues required 
for fast Na + channel inactivation. Proc. Natl. Acad. Sci. USA 89,10910- 
10914. 
Zhou, J., Spier, S. J., Beech, J., and Hoffman, E. P. (1994). Pathophysi- 
ology of sodium channelopathies: correlation of normal/mutant mRNA 
ratios with clinical phenotype in dominantly-inherited periodic paraly- 
sis. Hum. Mol. Genet. 3, 1599-1603. 
